chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID-19; COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Rheumatoid arthritis" (unspecified if ongoing); "Pnl allergies" (unspecified if ongoing). Concomitant medication(s) included: LIAN HUA QING WEN, start date: 27Jun2022, stop date: 04Jul2022. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant), outcome "unknown" and all described as "COVID-19". Therapeutic measures were taken as a result of covid-19, drug ineffective: Paxlovid from 04Jul2022 to 08Jul2022. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
tested Covid 19 positive; This is a spontaneous report from a contactable consumer (reported for himself).  The male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: solution for injection; Lot number and Expiration Date: UNKNOWN), via an unspecified route of administration on 28Jan2021, as a single dose for Covid-19 immunization. Medical history and concomitant medications were not reported. After a week Patient tested COVID-19 positive. Patient inquired what was the recommended date for the second dose. The outcome of the event of tested COVID-19 positive was unknown.   No follow-up attempts were Possible. No further information was expected
anaphylaxis; This is a spontaneous report from a contactable consumer.  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), on an unspecified date as single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  The patient experienced anaphylaxis on an unspecified date. The outcome of anaphylaxis was unknown.
Large black and blue mark on left arm slightly above the wrist, but approximately 12 inches down the arm from the injection area.   Could very well be a coincidence, but I did not bang my arm.
Patien was given a flu shot in the left arm, patient said her arm hurts since the vaccination date and she cannot raise her left arm past her breasts. Patient continues to have the problem to current day.
Patient felt dizzy and nauseated a few hours after receiving the vaccine. She was dizzy to the point of near syncope. She felt very disoriented and needed someone to drive her home.
Monovalent Booster dose administered after 9.1.22 - we rc'd email 9/9  after this was administered  to begin only using Bivalent Boosters after 9/1
pt seen for well check 2JUN97;nl H & P;given vax & 9JUN97 devel fever & rash was treated symptomatically;pt was put down 8PM & checked  9PM; then @ 10PM was noted to be cold & blue;taken to ER unable to resusitate;
Immediate reaction: Headache; brain fog; vertigo; sore arm; upper left chest pain; labored breathing  for the first week. Chest pain still continues to this day Nov, 17, 2021 I have seen numerous doctors and had EKG's and bloodwork since the shot.  I am currently seen a pain management specialist.
Soreness at injection site; joint pain; muscle pain; chills; Loss of appetite; Low-grade fever; This is a spontaneous report from a contactable other hcp. A 56 year old female patient received the first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number:EH9899), intramuscular on the left arm on 21Dec2020 09:45 at a SINGLE DOSE for covid-19 immunisation. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing known_allergies: Sulfa drugs. Concomitant medication included progesterone (PROGESTERONE), estradiol (ESTRADIOL), amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL). The patient experienced soreness at injection site, joint pain, muscle pain, chills, low-grade fever and loss of appetite on 21Dec2020. The outcome of the events was recovered.
She had an unusual reaction to the first one; Weakness on one side; her blood pressure went up (she needed an epi because her blood pressure skyrocketed); Did not feel normal; Pain inside of her head/really bad headache; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION COMPLICATION (She had an unusual reaction to the first one), ASTHENIA (Weakness on one side), BLOOD PRESSURE ABNORMAL (her blood pressure went up (she needed an EpiPen because her blood pressure skyrocketed)), FEELING ABNORMAL (Did not feel normal) and HEADACHE (Pain inside of her head/really bad headache) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (She had an unusual reaction to the first one), ASTHENIA (Weakness on one side), BLOOD PRESSURE ABNORMAL (her blood pressure went up (she needed an EpiPen because her blood pressure skyrocketed)), FEELING ABNORMAL (Did not feel normal) and HEADACHE (Pain inside of her head/really bad headache). The patient was treated with EPINEPHRINE for Blood pressure, at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (She had an unusual reaction to the first one), ASTHENIA (Weakness on one side), BLOOD PRESSURE ABNORMAL (her blood pressure went up (she needed an EpiPen because her blood pressure skyrocketed)), FEELING ABNORMAL (Did not feel normal) and HEADACHE (Pain inside of her head/really bad headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant drug reported. Nurse reported- Patient came for her second dose of the Moderna COVID-19 vaccine. They are unsure as to give the second dose or not. Treatment- EpiPen because her blood pressure skyrocketed.
Had a blood draw in left arm 12/24/2020. Eventually led to superficial venous thrombosis of left basilic vein confirmed by duplex us and ct angiogram w/ contrast. Indentured vein led to seek diagnosis and treatment
swelling of right upper eyelid and chills Narrative: had severe swelling of right upper eyelid requiring oral steroids to decrease the swelling.
On Oct 7th I was given the flu shot at hospital. The day after on 10/8/19 I felt numbness through my legs and arms around 12pm I went to see my primary doctor right after
Patient given pediatric/adolescent dose of Hep B. Patient advised of dose given. Patient advised of side effects, and verbalized understanding. No adverse reactions reported at this time.
4 seizures between 3:30 AM 3/3/05 and 11:15 AM 3/3/05. Seizures were with in 12 hours of vaccinations. Turned blue and was taken by ambulance to emergency room. ER doctor and neurologist advised to not receive the Pertussis portion of DTaP again. Extreme fussiness and irritability from 3/5/05 to 3/7/05. Information received from Discharge summary states eyes deviating upwards. msv
After returning from travel, I took a COVID test and it was positive. I took a second one later in the day; it was again positive. I was fatigued and had sinus issues, but those were normal for long travel. I had no other indications that I was ill.
This spontaneous report as receive from a pharmacist via a company representative refers to a 70 year old male patient. The patient had received an influenza vaccine (unspecified) (reported as unknown flu vaccine) about 2 weeks before vaccination with ZOSTAVAX, on appropriately 29-OCT-2013. On 12-NOV-2013 the patient was vaccinated with a dose of ZOSTAVAX (dose, route and lot # unspecified). Concomitant therapies included low dose prednisone(manufacturer unspecified). On 04-DEC-2013, the patient developed shingles after vaccination with ZOSTAVAX. The outcome of shingles was unknown. Additional information has been requested.
This spontaneous report as received from a registered nurse refers to a 24 year old female healthcare worker with drug allergy, no pertinent medical history. The patient had following drug allergies: BACTRIM-hives; doxycycline- vomiting; DEMEROL- nausea/hallucination; CIPRO-hives. No concomitant therapy involved. On 12-JUL-2013, a dose of VARIVAX (Merck) (lot# was reported as H018788, EXP date: 15-OC-2014), after reconstitution, sprayed out of the back end of the syring needle from the vial and went into the right eye of a healthcare worker who was preparing the VARIVAX (Merck) dose for administration to a patient. Healthcare worker reported to the nurse of experiencing stinging and burning in the right eye after this occurred. PQC filed because of excess pressure from VARIVAX (Merck) vial. The patient had eye staining test from eye kit. The patient was flushed eyes out with eye solution and applied patch to affected eye and sent home for rest. The patient had sought medical attentions as the event occurred at the provider office. At time of reporting, the patient was recovering from the events. Additional information has been requested.
Experienced massive blood clotting during following menstrual cycles, accompanied by migraine headache, shortness of breath, and fainting. These symptoms return each menstrual cycle since the second vaccine of the Moderna COVID-19 shot.
DVT under clavicle . Sudden Swelling, discoloring and numbness of left arm.
Child given vaccine that may have had temperature excursion (data logger failure) with stable fridge temps before & after. DOH determine the vaccine to be at risk & advised reporting & revaccination  Child had no ill effects this far
Moderna administered on 05/20/21 at approximately 1500 hours. R deltoid. No observable indications of adverse reaction upon completion of 15 minute post administration observation period.  At approx 2000 hours, small red wheals appeared on L anterolateral leg, 30 cm inferior to L knee. Urticaria worsens over 60 minutes. Diphenhydramine topical ointment applied to affected area. No further Tx. No further adverse effects noted or observed.
after waking up at 7am on 04/19/2021 and walking to the restroom i felt dizzy and went back to bed and at this point while laying down with eyes open the room was spinning.  i felt cold and shaky. At some point i had to go to the floor to get Welches gummies for the sugar this was about an hour after the experience and it felt to calm me down after 30 minutes. Sudden movements made me very dizzy. I went to the ER after my ex fiance came to my fathers house because no one else was home to take me.
pt recvd vax DEC95 & JAN96 pt exp idiopathic thrombocytopenia purpura & was hospitalized;reporter felt that the ITP was related to therapy w/varicella vax
urticarial rash, facial edema beginning 5 days after vaccine administration.  no other new exposures or recent illness.
Pt received vaccine at 16wks EGA, EDD 2/11/2022. Reported onset of pelvic pain and pubic symphysis pain within 48hrs of vaccination., persisting for 3 wks after first vaccine.
This spontaneous report as received from a certified medical assistant to a 15 year old patient of an unknown gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. Approximately in 2015 (reported as 27-AUG-2015 to 03-SEP-2015) the patient was vaccinated with improperly stored dose of GARDASIL lot # K010215 with expiration date 05-MAY-2017 or lot # K011562 with expiration date 08-APR-2017; dose and route of administration were not reported. No adverse experiences were reported. This is one of the several reports received from same reporter. Additional information has been requested.
Chills, aching for 24 hours Sore arm for 24 hours then less intense for about a week
pt recvd vax & devel two lesions on arm 2 wks p/vax;The nurse felt that the pt's exp was related to vax;No further details were provided;
inflammation in the face; This is a Spontaneous report from a contactable Other HCP reporting for a patient based on the information received by Pfizer Reference Number: GL-020821-3457).  A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took restylane on unspecified date. The patient previously took first dose of historical vaccine, bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) on an unspecified date as dose 1, single for covid-19 immunisation. It was reported that on an unspecified date, the patient experienced inflammation in the face where previous filler (Restylane) was injected in. Inflammation occurred within days of 2nd covid vaccination. No other information provided. The outcome of event was unknown.  No follow-up attempts are needed. Information on Lot/Batch number cannot be obtained. No further information is expected.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP). The reporter is the patient.  A 33-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 06Nov2021 as dose 3 (booster), single (Lot number: Ew 0172) at the age of 32 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "celiac disease" (unspecified if ongoing); "migraines" (unspecified if ongoing), notes: other medical history: migraines. Concomitant medication(s) included: INDAPAMIDE; TRAZODONE; JOLESSA. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant) all with onset May2022, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: Fibrin D dimer: (30May2022) Negative; SARS-CoV-2 test: (May2022) Negative, notes: after testing negative a few days prior; (30May2022) Positive; Troponin: (30May2022) Negative; X-ray: (30May2022) Normal. Therapeutic measures were taken as a result of covid-19.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Drug ineffective depends on many factors including pharmacokinetics, severity of disease and patient general health condition. However on conservative basis, the possible causality cannot be excluded.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021 at 2:49 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 12-Jan-2021 at 2:49 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 65.28 for dose administered on 12-Jan-2021.  Concomitant products were not provided.  On 12-Jan-2021, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 08-Jan-2021, vial was moved to clinic on 12-Jan-2021. 3 vials were sent to clinic. Vaccine BUD date was 07-Feb-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.   This case was linked to MOD-2022-566976 (Patient Link).
Swollen eye; low grade fever; slight headache; fatigue; 13-year-old female patient received BNT162B2; This is a spontaneous report from a contactable consumer (patient). A 13-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in the left arm on 13May2021 14:15 (batch/lot number: PFIZEREW0179) as 1st dose, single for COVID-19 immunization. Medical history included known allergies to amoxicillin. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No Covid prior to vaccination and was not Covid tested post vaccination. The patient experienced swollen eye, low grade fever (99.5 F), slight headache, fatigue; all on 14May2021 14:00. Treatment was received for the adverse events which included diphenhydramine hcl (BENADRYL). The outcome of the events was recovering.  Information on lot/batch number was available. Follow-up attempts are completed. No further information is expected.
Changes in menstrual period. Severe abdominal cramps, migraine, nausea / vomiting
No adverse event but did receive the wrong vaccine.  She should have received a Pfizer Bivalent booster instead of the regular Pfizer booster
Body aches, chills, sneezing, coughing, tightness in chest.
This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in an adult patient who received Herpes zoster (Shingle's vaccine).    On an unknown date, the patient received Shingle's vaccine. On an unknown date, unknown after receiving Shingle's vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingle's vaccine.  Additional details were provided as follows: The reporter was patient's friend. The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The reporter stated his or her friend got the shingles even after receiving the shingles vaccine. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary vaccination schedule for shingles, laboratory test confirmation and time to onset for shingles were unknown at the time of reporting.
Hives/raised rash that has shown up all over my body. It is worse in the morning and evenings. The rash migrates and does not stay in one place. No other environmental, food, etc. factors that would answer for this sudden rash.
Information has been received from a physician concerning a patient who was vaccinated with a dose of ZOSTAVAX (lot# not available) and subsequently developed shingles "6 months after receiving the vaccine."  It was unknown whether medical attention was sought.  The outcome was unknown.  There was no product quality complaint.  The patient was enrolled in a program to identify if VZV is present and if it is present to identify if it is associated with wild-type (WT) VZV strain or with the Oka/Merck vaccine VZV strain.  Additional information has been requested.
patient had fever of 102 not lowered by Tylenol , stomach cramps, diarrhea, nausea  body aches general malaise consistent with Covid 19 vaccine infection she had earlier in the year
Syncope 5 minutes after administration of Fluvirin mdv vaccine. Patient regained consciousness within 30 seconds.
I had a sore arm and tired for about a day after receiving the vaccine. On 05/01/2023, I tested positive for COVID-19. I had a fever, chills and body aches. I contacted my doctor and got the prescription for Paxlovid. I tolerated the medication without any complications. As of today, I have a head cold and still testing positive for COVID-19. I am taking cold medicine to help with my symptoms.
soreness on 5/18/99 but used arm, slept on it @ noc;5/19/99 awakened w/migraine h/a, nausea, pain severe in arm;did not sleep well;advised to apply ice & call back;still in pain;inj area hot, not swollen;pain spread to trapezius muscle;
Experienced fever, body aches and chills 3 days after receiving the 2nd dose. Around 9 o'clock in the evening I started having palpitations. Heart rate reached 170 bpm, tracked by my apple watch. Went to the ER. I was diagnosed with sepsis. Fever was 102.7, HR wouldn't drop below 105bpm. Procalcitonin and lactic acid were all elevated. I was given 5 liters of fluids that night. Was then started on Vancomycin and cefepime the following morning. I was in the hospital for 2 nights.
Patient fainted after (2 minutes) shot. Fell backwards in waiting area, bumping buttocks 1st & back of head 2nd on floor. Pt. seemed confused at first, was pale & warm (per pt.) said he felt dizzy, looked to be weak & complained of visual disturbances. Placed pt. on back with feet elevated, gave water (cold) to sip. No loss of consciousness.
Urticaria developed approximently 2 hours after administration of vaccines.  Patient seen in office given Benedryl PO and dexamethasone IM.  No respiratory difficulty but condition did not improved and patient was referred to ER.
Vaccine was administered on 10/12, B-12 shot the next day. Severe arm pain on the following day.
Sore throat on 14 Oct 2022, again on 15 Oct 2022.  Tested at home, positive for Covid 19.  Went to Little Clinic for confirmation test the same day.  No treatment administered because I had been on three courses of progressively stronger antibiotics from The Little Clinic for ear infection, and since I had been having cold and sinus like symptoms for a month (tested negative for covid a few weeks prior), and any possible exposure data wasn't known, we couldn't pinpoint a date for Covid symptoms.